RBI Expands Gold Hedging Options for Residents Amidst Price Surge

In response to the soaring gold prices, expected to surpass $2700 per ounce this year amidst escalating geopolitical tensions in the Middle East, the Reserve Bank of India (RBI) announced a significant policy amendment. This move allows resident entities to diversify their hedging strategies against gold price volatility in overseas markets.

Policy Update

Effective immediately, residents can now utilize Over-the-Counter (OTC) derivatives in addition to derivatives traded on exchanges in the International Financial Services Centre (IFSC) for managing gold price risks. This expands the avenues for hedging gold exposure, offering residents enhanced flexibility in risk management.

Background

Previously, resident entities were permitted to hedge their exposure to gold price risks on exchanges in the IFSC recognized by the International Financial Services Centres Authority (IFSCA), since December 12, 2022.

Key Quote from RBI

“To provide further flexibility to resident entities to hedge their exposures to price risk of gold, it has now been decided to permit resident entities to hedge their exposures to price risk of gold using OTC derivatives in the IFSC in addition to the derivatives on the exchanges in the IFSC,” the central bank stated.

By expanding the options for gold hedging, the RBI aims to empower residents to better navigate the volatility in gold prices, thereby enhancing overall risk management capabilities.

Piyush Shukla

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

17 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

18 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

19 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

20 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

20 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

21 hours ago